Arvind Utchanah
Director of Finance/CFO at KNIGHT THERAPEUTICS INC.
Net worth: 153 413 $ as of 31/03/2024
Arvind Utchanah active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KNIGHT THERAPEUTICS INC. | Director of Finance/CFO | 30/03/2020 | - |
| Public Communications Contact | - | - | |
| Corporate Officer/Principal | 20/06/2016 | 30/03/2020 |
Career history of Arvind Utchanah
Former positions of Arvind Utchanah
| Companies | Position | Start | End |
|---|---|---|---|
| PALADIN LABS INC. | Comptroller/Controller/Auditor | 01/01/2012 | 01/06/2016 |
| Director of Finance/CFO | 01/01/2012 | 01/06/2016 |
Training of Arvind Utchanah
| McGill University | Undergraduate Degree |
| Concordia University | Graduate Degree |
Statistics
International
| Canada | 5 |
Operational
| Director of Finance/CFO | 2 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KNIGHT THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
- Stock Market
- Insiders
- Arvind Utchanah
- Experience
